PALISADE BIO, INC. — Director's Dealing 2019

Oct 11, 2019

SEC Form 4/A — Form 4/A

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2019-07-01

Reporting Person: OGILVIE SCOTT VARDE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-01	Common Stock Purchase Option	$6.002	A	10106	Acquired	2029-07-01	Common Stock (10106)	Direct

Footnotes

F1: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

F2: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019.

F3: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported.